Selection of a <scp>PD</scp> ‐1 blocking antibody from a novel fully human phage display library-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Selection of a PD ‐1 blocking antibody from a novel fully human phage display library

Published:2022-11-16 Issue:12 Volume:31 Page:
ISSN:0961-8368
Container-title:Protein Science
language:en
Short-container-title:Protein Science

Author:

Peissert Frederik¹²^ORCID,Plüss Louis¹³,Giudice Anna Maria¹,Ongaro Tiziano⁴,Villa Alessandra¹,Elsayed Abdullah¹³,Nadal Lisa¹,Dakhel Plaza Sheila¹,Scietti Luigi⁴,Puca Emanuele¹,De Luca Roberto¹,Forneris Federico⁴^ORCID,Neri Dario¹³⁵

Affiliation:

1. Philochem AG Otelfingen Switzerland

2. Biomolecular Sciences and Biotechnology University School for Advanced Studies IUSS Pavia Pavia Italy

3. Department of Chemistry and Applied Biosciences Swiss Federal Institute of Technology (ETH Zürich) Zürich Switzerland

4. The Armenise‐Harvard Laboratory of Structural Biology, Department of Biology and Biotechnology University of Pavia Pavia Italy

5. Philogen SpA Sovicille (SI) Italy

Funder

Dipartimenti di Eccellenza

Fondazione Italiana per la Ricerca sul Cancro

Publisher

Wiley

Subject

Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pro.4486

Reference65 articles.

1. Roles of the immune system in cancer: from tumor initiation to metastatic progression

2. The blockade of immune checkpoints in cancer immunotherapy

3. A decade of immune-checkpoint inhibitors in cancer therapy

4. In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates

5. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond Small Molecules: Antibodies and Peptides for Fibroblast Activation Protein Targeting Radiopharmaceuticals;Pharmaceutics;2024-02-29

2. A fully human monoclonal antibody targeting Semaphorin 5A alleviates the progression of rheumatoid arthritis;Biomedicine & Pharmacotherapy;2023-12

3. Adapting Neutralizing Antibodies to Viral Variants by Structure‐Guided Affinity Maturation Using Phage Display Technology;Global Challenges;2023-08-21

4. Inside PD-1/PD-L1,2 with their inhibitors;European Journal of Medicinal Chemistry;2023-08

5. Generation of a novel fully human non-superagonistic anti-CD28 antibody with efficient and safe T-cell co-stimulation properties;mAbs;2023-06-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3